Kaleido Biosciences, Inc.
We are a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health.
$20.00 - $22.00
February 28, 2019
GOLDMAN SACHS & CO. LLC
To view the prospectus for Kaleido Biosciences, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253